Items where Author is "Reck, Martin"

Article

Peters, Solange and Schulz, Christian and Reck, Martin and Prabhash, Kumar and Kowalski, Dariusz and Szczesna, Aleksandra and Han, Baohui and Rittmeyer, Achim and Talbot, Toby and Vicente, David and Califano, Raffaele and Cortinovis, Diego and Le, Anh tuan and Huang, Dingzhi and Liu, Geoffrey and Cappuzzo, Federico and Contreras, Jessica reyes and Palmero, Ramon and Mak, Milena perez and Popat, Sanjay and Hu, Youyou and Morris, Stefanie and Srivastava, Minu K. and Kaul, Monika and Graupner, Vilma and Gitlitz, Barbara and Lee, Siow ming (2025) Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study. JOURNAL OF THORACIC ONCOLOGY, 20 (12). pp. 1843-1850. ISSN 1556-0864, 1556-1380

Bischoff, Philip and Reck, Martin and Overbeck, Tobias and Christopoulos, Petros and Rittmeyer, Achim and Lueders, Heike and Kollmeier, Jens and Kulhavy, Jonas and Kemper, Marcel and Reinmuth, Niels and Roeper, Julia and Janning, Melanie and Sommer, Linna and Aguinarte, Lukas and Koch, Myriam and Wiesweg, Marcel and Wesseler, Claas and Waller, Cornelius F. and Kauffmann-Guerrero, Diego and Stenzinger, Albrecht and Stephan-Falkenau, Susann and Trautmann, Marcel and Lassmann, Silke and Tiemann, Markus and Klauschen, Frederick and Sebastian, Martin and Griesinger, Frank and Wolf, Juergen and Loges, Sonja and Frost, Nikolaj (2024) Outcome of First-Line Treatment With Pembrolizumab According to KRAS / TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 19 (5). pp. 803-817. ISSN 1556-0864, 1556-1380

Lee, Siow Ming and Schulz, Christian and Prabhash, Kumar and Kowalski, Dariusz and Szczesna, Aleksandra and Han, Baohui and Rittmeyer, Achim and Talbot, Toby and Vicente, David and Califano, Raffaele and Cortinovis, Diego and Le, Anh Tuan and Huang, Dingzhi and Liu, Geoffrey and Cappuzzo, Federico and Contreras, Jessica Reyes and Reck, Martin and Palmero, Ramon and Mak, Milena Perez and Hu, Youyou and Morris, Stefanie and Hoeglander, Elen and Connors, Mary and Biggane, Alice M. and Vollan, Hans Kristian and Peters, Solange (2023) First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study. LANCET, 402 (10400). pp. 451-463. ISSN 0140-6736, 1474-547X

Christopoulos, Petros and Kluck, Klaus and Kirchner, Martina and Lueders, Heike and Roeper, Julia and Falkenstern-Ge, Roger-Fei and Szewczyk, Marlen and Sticht, Florian and Saalfeld, Felix C. and Wesseler, Claas and Hackanson, Bjoern and Dintner, Sebastian and Faehling, Martin and Kuon, Jonas and Janning, Melanie and Kauffmann-Guerrero, Diego and Kazdal, Daniel and Kurz, Sylke and Eichhorn, Florian and Bozorgmehr, Farastuk and Shah, Rajiv and Tufman, Amanda and Wermke, Martin and Loges, Sonja and Brueckl, Wolfgang M. and Schulz, Christian and Misch, Daniel and Frost, Nikolaj and Kollmeier, Jens and Reck, Martin and Griesinger, Frank and Grohe, Christian and Hong, Jin-Liern and Lin, Huamao M. and Budczies, Jan and Stenzinger, Albrecht and Thomas, Michael (2022) The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions. EUROPEAN JOURNAL OF CANCER, 170. pp. 106-118. ISSN 0959-8049, 1879-0852

Conference or Workshop Item

Shah, Rajiv and Klotz, Laura V. and Christoph, Daniel Christian and Schulmann, Karsten and Kopp, Hans-Georg and Reinmuth, Niels and Ried, Michael and de Wit, Maike and Buchmeier, Eva Lotte and Wesseler, Claas and Reck, Martin and Bethge, Andre and Waller, Cornelius and Hoffknecht, Petra and Hackanson, Bjoern and Schneider, Marc A. and Behnisch, Rouven and Christopoulos, Petros and Eichhorn, Martin E. and Thomas, Michael (2023) Nivolumab with chemotherapy in pleural mesothelioma after surgery: The NICITA trial. In: Annual Meeting of the American Society of Clinical Oncology (ASCO), June 02-06, 2023, Chicago, IL.